POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

Biotechnology Research • Indianapolis, Indiana, United States • 51-100 Employees

Company overview

Headquarters	4850 W 78th St, Indianapolis, Indiana 46268, US
Phone number	+18005455979
Websites	pointbiopharma.com lilly.com
Keywords	Cancer, Oncology, Radiopharmaceutical, Radioligand
Founded	2019
Employees	51-100
Socials

Key Contacts at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

Clara Schmidt

Director Of Clinical Research

Michael Abel

Director, Environmental Health And Radiation Safety

Fred Restaino

Sr. Director Clinical Supply Chain

Michelle Bousquet

Associate Director, Clinical Program Manager Early Phase

William Skarupa

Sr Director Process / Plant Engineering

Jennifer Walker

Sr. Director, Qa/Qc

Bei Wang

Director Qa/Qc

Sue Leeson

Chief Executive Officer

Matt Vincent

Founder

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company Email Formats

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@pointbiopharma.com), used 55% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@pointbiopharma.com	55%
{first name}{last name}	johndoe@pointbiopharma.com	45%

About POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company revenue & valuation

Annual revenue	$11,200,000
Revenue per employee	$160,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$35,800,000
Total funding	$125,000,000

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Senior

Director

Employees by Department

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company has 37 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-10-13	14	$125,000,000

Funding Insights

$125,000,000

Total funding amount

$125,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company is located in Indianapolis, Indiana, US.

You can reach POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company at +18005455979.

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company has raised a total of $125,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.